CXCR4 Rabbit Polyclonal Antibody
CNY 5,808.00
货期*
5周
规格
Cited in 2 publications. |
经常一起买 (1)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
CNY 300.00
CNY 1,430.00
Specifications
Product Data | |
Applications | FC, IF, IHC, WB |
Recommend Dilution | WB: 1 - 2 ug/mL, IP, ICC: 10 ug/g/mL, IF: 10 ug/g/mL, FACS: 10 ug/mL |
Reactivity | Human, Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | CXCR4 antibody was raised against a peptide corresponding to 14 amino acids near the amino terminus of human CXCR4. The immunogen is located within the first 50 amino acids of CXCR4. |
Formulation | PBS containing 0.02% sodium azide. |
Purification | Antibody is DEAE purified |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Gene Name | C-X-C motif chemokine receptor 4 |
Database Link | |
Background | Human immunodeficiency virus (HIV) and related viruses require coreceptors, in addition to CD4, to infect target cells. Some G protein-coupled receptors including CCR5, CXCR4, CCR3, CCR2b and CCR8 in the chemokine receptor family, and four new human molecules GPR15, STRL33, GPR1 and V28 were recently identified as HIV coreceptors. Among them, CXCR4 (fusin, LESTR or HUMSTR) is a principal coreceptor for T-cell tropic strains of HIV-1 fusion and entry of human white blood cells. CXCR4 is also required for the infection by dual-tropic strains of HIV-1 and mediates CD-4 independent infection by HIV-2. The a-chemokine SDF-1 is the ligand for CXCR4 and prevents infection by T-tropic HIV-1. CXCR4 associates with the surface CD4-gp120 complex before HIV enters target cells. CXCR4 messenger RNA levels correlated with HIV-1 permissiveness in diverse human cell types. Antibodies to CXCR4 block HIV-1 and HIV-2 fusion and infection of human target cells. The amino-terminal domain and the second extracellular loop of CXCR4 serve as HIV binding sites. |
Synonyms | CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM |
Reference Data |
Citations (2)
The use of this Antibodies has been cited in the following citations: |
---|
Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
,null,
Cancer drug resistance (Alhambra, Calif.)
,PubMed ID 33073205
[CXCR4]
|
Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
,Miller, A;Garcia, P;Gamblin, T;Vance, R;Yoon, K;,
CDR
[CXCR4]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...